| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Daniel Tardiff is Chief Scientific Officer at CAMP. Daniel Tardiff's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider.
Daniel Tardiff has 3 Form 4 filings on record from December 2025 to August 2026, all as Chief Scientific Officer at Camp4 Therapeutics (CAMP), 2025–2026.
The 3 reported transactions were 2 option or other derivative awards and 1 open-market sale.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $8K.
The only open-market sale was 1,738 shares of CAMP at an average $4.76 on August 19, 2026, about $8K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | CAMP Camp4 Therapeutics Corporation | Chief Scientific Officer | Sell | 1,738 | $4.76 | $8,272.88 | -100% | - | - |